Empery Asset Management, LP — 13F Holdings & Portfolio
CIK 1469336 · latest 13F-HR filed 2026-05-08
Empery Asset Management, LP manages $83.0M in 13F-reported U.S. long-equity assets across 32 reported positions as of its 2026-03-31 13F-HR filing. Its largest disclosed positions are XFOR (44.50%), EMPD (14.93%), DTIL (13.04%). Quarter over quarter (versus its 2025-12-31 filing) the fund opened 13 new positions, exited 12, added to 5, and trimmed 13.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
$83.0M
Long-equity book
32
Distinct positions
2026-03-31
Filed 2026-05-08
+13 / −12 / ↑5 / ↓13
vs 2025-12-31
| Name | Title / Status | Ownership | Type |
|---|
Top Adds (vs prior quarter)
- PRECISION BIOSCIENCES INC$1.7M +18.6%
- MARIS TECH LTD$9.2K +25.8%
- SPECTRAL AI INC$3.7K +24.4%
- NEXERA TECHNOLOGIES LTD$2.0K +49.1%
- MEDICUS PHARMA LTD$1.8K +18.7%
Top Trims
- IMPERIAL PETE INC-$7.8M -67.4%
- CRITICAL METALS CORP-$2.4M -69.3%
- TALPHERA INC-$1.1M -71.0%
- EMPERY DIGITAL INC-$981.7K -7.3%
- TENAYA THERAPEUTICS INC-$883.9K -22.9%
New Positions
- VENU HLDG CORP$3.3M
- U S ENERGY CORP DEL$1.7M
- SCYNEXIS INC$1.7M
- CYNGN INC$1.6M
- JAGUAR URANIUM CORP$1.3M
Exited Positions
- Immuneering Corp$17.6M
- Aduro Clean Technologies Inc$5.9M
- Eos Energy Enterprises Inc$2.9M
- Surrozen Inc$2.3M
- Kazia Therapeutics Ltd$1.2M
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | X4 PHARMACEUTICALS INC | XFOR | 98420X202 | $36.9M | 44.50% | 8,944,118 | SH |
| 2 | EMPERY DIGITAL INC | EMPD | 92864V608 | $12.4M | 14.93% | 2,930,345 | SH |
| 3 | PRECISION BIOSCIENCES INC | DTIL | 74019P207 | $10.8M | 13.04% | 1,968,879 | SH |
| 4 | IMPERIAL PETE INC | IMPP | Y3894J187 | $3.8M | 4.52% | 877,645 | SH |
| 5 | VENU HLDG CORP | VENU | 92333E104 | $3.3M | 4.02% | 1,007,729 | SH |
| 6 | TENAYA THERAPEUTICS INC | TNYA | 87990A106 | $3.0M | 3.58% | 4,286,933 | SH |
| 7 | U S ENERGY CORP DEL | USEG | 911805307 | $1.7M | 2.04% | 1,917,844 | SH |
| 8 | SCYNEXIS INC | SCYX | 811292200 | $1.7M | 2.04% | 1,847,826 | SH |
| 9 | CYNGN INC | CYN | 23257B305 | $1.6M | 1.92% | 957,784 | SH |
| 10 | JAGUAR URANIUM CORP | JAGU | 47010E108 | $1.3M | 1.61% | 487,500 | SH |
| 11 | SATELLOS BIOSCIENCE INC | MSLE | 80401L803 | $1.3M | 1.56% | 230,100 | SH |
| 12 | CRITICAL METALS CORP | CRML | G2662B103 | $1.0M | 1.26% | 132,039 | SH |
| 13 | UR-ENERGY INC | URG | 91688R108 | $924.0K | 1.11% | 620,136 | SH |
| 14 | PROMIS NEUROSCIENCES INC | PMN | 74346M505 | $766.5K | 0.92% | 60,353 | SH |
| 15 | SUPER LEAGUE ENTERPRISE INC | SLE | 86804F509 | $491.8K | 0.59% | 132,917 | SH |
| 16 | TALPHERA INC | TLPH | 00444T209 | $441.0K | 0.53% | 590,481 | SH |
| 17 | BENITEC BIOPHARMA INC | BNTC | 08205P209 | $324.2K | 0.39% | 30,440 | SH |
| 18 | BRIACELL THERAPEUTICS CORP | BCTXL | 107930125 | $309.0K | 0.37% | 300,000 | SH |
| 19 | ABITS GROUP INC | ABTS | G6S34K113 | $266.1K | 0.32% | 172,761 | SH |
| 20 | PARAZERO TECHNOLOGIES LTD | PRZO | M7S13T102 | $217.6K | 0.26% | 282,199 | SH |
| 21 | NASUS PHARMA LTD | NSRX | M7071P109 | $101.7K | 0.12% | 45,803 | SH |
| 22 | BRIACELL THERAPEUTICS CORP | BCTXZ | 107930117 | $93.3K | 0.11% | 666,600 | SH |
| 23 | NUTRIBAND INC | NTRBW | 67092M125 | $45.0K | 0.05% | 40,218 | SH |
| 24 | MARIS TECH LTD | MTEKW | M68057112 | $44.9K | 0.05% | 297,600 | SH |
| 25 | RENATUS TACTICAL ACQUIS | RTACW | G7490F127 | $23.0K | 0.03% | 50,000 | SH |
| 26 | NEUROSENSE THERAPEUTICS LTD | NRSNW | M74240116 | $20.1K | 0.02% | 100,402 | SH |
| 27 | SPECTRAL AI INC | MDAIW | 84757T113 | $18.7K | 0.02% | 33,336 | SH |
| 28 | CEA INDUSTRIES INC | BNCWW | 86887P119 | $15.3K | 0.02% | 500,000 | SH |
| 29 | MEDICUS PHARMA LTD | MDCXW | 58471K111 | $11.5K | 0.01% | 12,100 | SH |
| 30 | NEXERA TECHNOLOGIES LTD | NEXRW | M61472110 | $6.1K | 0.01% | 360,577 | SH |
| 31 | NEXGEL INC | NXGLW | 65344E115 | $5.4K | 0.01% | 90,000 | SH |
| 32 | FGI INDUSTRIES LTD | FGIWW | G3302D111 | $2.7K | 0.00% | 83,928 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-03-31 | 2026-05-08 | $83.0M | 32 | 0000902664-26-002332 |
| 2025-12-31 | 2026-02-11 | $113.4M | 31 | 0000902664-26-000854 |